Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity
Luppi, Mario, Forghieri, Fabio, Potenza, LeonardoJournal:
Clinical Infectious Diseases
DOI:
10.1093/cid/ciaa323
Date:
May, 2020
File:
PDF, 107 KB
2020